Cite
HARVARD Citation
Seefried, L. et al. (2022). Efficacy of Zoledronic Acid in the Treatment of Nonmalignant Painful Bone Marrow Lesions: A Triple‐Blind, Randomized, Placebo‐Controlled Phase III Clinical Trial (ZoMARS). Journal of bone and mineral research. pp. 420-427. [Online].